---
category: news
title: "Verge Starts First-in-human Trial of Its Novel PIKfyve Inhibitor for ALS"
excerpt: "Verge Genomics has launched a first-in-human clinical trial testing VRG50635, its AI-developed PIKfyve inhibitor treatment candidate for ALS."
publishedDateTime: 2022-11-03T12:48:00Z
originalUrl: "https://alsnewstoday.com/news/verge-starts-first-human-trial-pikfyve-inhibitor-als/"
webUrl: "https://alsnewstoday.com/news/verge-starts-first-human-trial-pikfyve-inhibitor-als/"
type: article

provider:
  name: ALS News Today
  domain: alsnewstoday.com

topics:
  - AI in Healthcare
  - AI

secured: "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;B27F+4XTpEf9CyX7Gdk9zA=="
---

